Aktis Oncology AKTS
$16.15 −$0.25 (-1.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.46 +1.92%
Open$16.32
Prev close$16.40
Day range$16.00 – $16.74
Volume375.0K
Market cap$901.14M
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts4
Average target$36.50+126.0% vs. price
- Buy 100%
Low $34.00Now $16.15Avg $36.50High $40.00
Recent rating changes
The last 20 actions on file set price targets from $33.00 to $40.00, averaging $36.19.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | BofA Securities | BUY | $34.00 |
| 13 Nov 2026 | Oppenheimer | BUY | $40.00 |
| 2 Oct 2026 | Wedbush | BUY | $35.00 |
| 9 Sep 2026 | Oppenheimer | BUY | $40.00 |
| 19 Aug 2026 | Wedbush | BUY | $35.00 |
| 18 Aug 2026 | BMO Capital | BUY | $37.00 |
| 14 Aug 2026 | William Blair | BUY | – |
| 14 Aug 2026 | BofA Securities | BUY | $34.00 |
| 14 Aug 2026 | J.P. Morgan | BUY | $33.00 |
| 14 Jul 2026 | William Blair | BUY | – |
| 14 Jul 2026 | J.P. Morgan | BUY | $33.00 |
| 16 Jun 2026 | Raymond James | BUY | $40.00 |
| 15 Jun 2026 | Raymond James | BUY | $40.00 |
| 12 Jun 2026 | Raymond James | BUY | $40.00 |
| 3 Jun 2026 | H.C. Wainwright | BUY | $35.00 |
| 2 Jun 2026 | H.C. Wainwright | BUY | $35.00 |
| 1 Jun 2026 | William Blair | BUY | – |
| 31 May 2026 | BofA Securities | BUY | $34.00 |
| 27 May 2026 | William Blair | BUY | – |
| 27 May 2026 | BofA Securities | BUY | $34.00 |
No comments yet — be the first to weigh in on AKTS.
Sign in to join the discussion.